Boutique real estate advisory and development firm focused on commercial and mixed‑use projects across regional markets, offering asset management, project delivery and capital advisory to private investors and family offices. Clune & Associates Ltd. positions itself as a mid‑market operator with hands‑on development capability, structuring equity/joint‑venture investments and unlocking value through active asset repositioning.
Boutique real estate advisory and development firm focused on commercial and mixed‑use projects across regional markets, offering asset management, project delivery and capital advisory to private investors and family offices. Clune & Associates Ltd. positions itself as a mid‑market operator with hands‑on development capability, structuring equity/joint‑venture investments and unlocking value through active asset repositioning.
Focuses on mid‑market commercial and mixed‑use real estate investments across regional markets, emphasizing value‑add repositioning and hands‑on project delivery. Deploys capital through structured equity, joint ventures and preferred equity to private investors and family offices, underwriting deals with downside protection, conservative leverage and measurable cash‑on‑cash targets. Strategic edge derives from local market sourcing, active asset management and integrated development capability to accelerate stabilization and realize asymmetric returns over a 3–7 year horizon.
Focuses on mid‑market commercial and mixed‑use real estate investments across regional markets, emphasizing value‑add repositioning and hands‑on project delivery. Deploys capital through structured equity, joint ventures and preferred equity to private investors and family offices, underwriting deals with downside protection, conservative leverage and measurable cash‑on‑cash targets. Strategic edge derives from local market sourcing, active asset management and integrated development capability to accelerate stabilization and realize asymmetric returns over a 3–7 year horizon.
| Trades 988 | Longs Won 752/988 76% | Profit Factor 26.01 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $439,370.58 |
| Average Win $148,839.56 | Best Trade (Aug 17) $6.99M | Sharpe Ratio -11.42 |
| Average Loss -$18,237.23 | Worst Trade (Aug 20) -$386,172.44 | Z-Score 16.05 (100%) |
| Commissions $0 | Avg. Trade Length 11m 2w 4d | Expectancy $108,930.52 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 37,037 | 33,333 | 29,630 | 25,926 | 22,222 | 18,519 | 14,815 | 11,111 | 7,407 | 3,704 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 35,111 | $8.98M | $10.85M | - | $1.87M | 20.82% | -7.354% |
ABBV AbbVie Inc. | 19,033 | $3.44M | $4.78M | - | $1.33M | 38.76% | -2.513% |
ABOS Acumen Pharmaceuticals, Inc. | 16,500 | $28,380 | $35,475 | - | $7,095 | 25% | -0.922% |
ABT Abbott Laboratories | 12,530 | $1.42M | $1.32M | - | -$99,918 | -7.02% | +0.085% |
AGG iShares Core U.S. Aggregate Bond ETF | 9,236 | $898,825.82 | $899,309.32 | - | $483.5 | 0.05% | -0.256% |
AMAT Applied Materials, Inc. | 357 | $258,111 | $181,238.19 | - | -$76,872.81 | -29.78% | +1.176% |
AMZN Amazon.com Inc | 8,701 | $1.87M | $2.36M | - | $496,393.7 | 26.59% | +15.321% |
AON Aon plc | 2,304 | $827,504.5 | $830,707.18 | - | $3,202.68 | 0.39% | -1.642% |
AVDE Avantis International Equity ETF | 32,010 | $2.04M | $2.92M | - | $881,964.73 | 43.28% | -0.458% |
AVDS Avantis International Small Cap Equity ETF | 3,982 | $270,312.47 | $304,184.98 | - | $33,872.51 | 12.53% | -0.599% |
AVDV Avantis International Small Cap Value ETF | 98,148 | $9.22M | $10.27M | - | $1.05M | 11.43% | -0.476% |
AVEM Avantis Emerging Markets Equity ETF | 50,845 | $3.26M | $4.55M | - | $1.29M | 39.44% | +0.101% |
AVGO Broadcom Inc. | 1,660 | $414,146.38 | $646,204.8 | - | $232,058.42 | 56.03% | +0.371% |
AVIV Avantis International Large Cap Value ETF | 72,725 | $4.31M | $5.87M | - | $1.56M | 36.25% | -0.567% |
AVLV Avantis U.S. Large Cap Value ETF | 81,585 | $5.64M | $7.52M | - | $1.88M | 33.38% | +0.141% |
AVSC Avantis U.S. Small Cap Equity ETF | 18,806 | $1.06M | $1.36M | - | $304,823.12 | 28.88% | -0.166% |
AVSF Avantis Short-Term Fixed Income ETF | 29,879 | $1.39M | $1.39M | - | -$1,282.02 | -0.09% | -0.022% |
AVUS Avantis U.S. Equity ETF | 7,771 | $868,622 | $991,579.6 | - | $122,957.6 | 14.16% | +0.567% |
AVUV Avantis U.S. Small Cap Value ETF | 17,438 | $1.71M | $2.18M | - | $478,756.23 | 28.07% | +0.032% |
BND Vanguard Total Bond Market Index Fund | 6,780 | $494,584.91 | $489,719.4 | - | -$4,865.51 | -0.98% | -0.262% |